Citigroup upgraded Calithera Biosciences Inc. (Nasdaq: CALA) from a Neutral rating to a Buy rating lifting the stock price $1.15 to close at $8.10.
Cala Biosciences upgraded
February 16, 2018 at 19:15 PM EST
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|